These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 28362129)
21. Local palliative therapies for unresectable malignant biliary obstruction: radiofrequency ablation combined with stent or biliary stent alone? An updated meta-analysis of nineteen trials. Song S; Jin H; Cheng Q; Gong S; Lv K; Lei T; Tian H; Li X; Lei C; Yang W; Yang K; Guo T Surg Endosc; 2022 Aug; 36(8):5559-5570. PubMed ID: 35296949 [TBL] [Abstract][Full Text] [Related]
22. Percutaneous intraductal radiofrequency ablation is a safe treatment for malignant biliary obstruction: feasibility and early results. Mizandari M; Pai M; Xi F; Valek V; Tomas A; Quaretti P; Golfieri R; Mosconi C; Guokun A; Kyriakides C; Dickinson R; Nicholls J; Habib N Cardiovasc Intervent Radiol; 2013 Jun; 36(3):814-9. PubMed ID: 23232859 [TBL] [Abstract][Full Text] [Related]
23. Endoscopic radiofrequency ablation may be preferable in the management of malignant biliary obstruction: A systematic review and meta-analysis. Zheng X; Bo ZY; Wan W; Wu YC; Wang TT; Wu J; Gao DJ; Hu B J Dig Dis; 2016 Nov; 17(11):716-724. PubMed ID: 27768835 [TBL] [Abstract][Full Text] [Related]
24. Updated evidence on the clinical impact of endoscopic radiofrequency ablation in the treatment of malignant biliary obstruction. Inoue T; Yoneda M Dig Endosc; 2022 Jan; 34(2):345-358. PubMed ID: 34107114 [TBL] [Abstract][Full Text] [Related]
25. Percutaneous intraductal radiofrequency ablation combined with biliary stent placement for treatment of malignant biliary obstruction. Yu T; Zhang W; Li C; Wang C; Gong G; Wang L; Li G; Chen Y; Wang X Abdom Radiol (NY); 2020 Nov; 45(11):3690-3697. PubMed ID: 32277241 [TBL] [Abstract][Full Text] [Related]
26. Percutaneous Intraductal Radiofrequency Ablation for Malignant Biliary Obstruction Caused by Recurrence and Metastasis after Primary Tumor Resection. Cui W; Fan W; Lu M; Zhang Y; Yao W; Wang Y; Li J Oncol Res Treat; 2018; 41(1-2):22-28. PubMed ID: 29393244 [TBL] [Abstract][Full Text] [Related]
27. Lymphocyte-to-monocyte ratio predicts survival after radiofrequency ablation for colorectal liver metastases. Facciorusso A; Del Prete V; Crucinio N; Serviddio G; Vendemiale G; Muscatiello N World J Gastroenterol; 2016 Apr; 22(16):4211-8. PubMed ID: 27122671 [TBL] [Abstract][Full Text] [Related]
28. Percutaneous Intraductal Radiofrequency Ablation Combined with Biliary Stent Placement for Nonresectable Malignant Biliary Obstruction Improves Stent Patency but not Survival. Wang J; Zhao L; Zhou C; Gao K; Huang Q; Wei B; Gao J Medicine (Baltimore); 2016 Apr; 95(15):e3329. PubMed ID: 27082582 [TBL] [Abstract][Full Text] [Related]
29. Intraductal Radiofrequency Ablation Followed by Locoregional Tumor Treatments for Treating Occluded Biliary Stents in Non-Resectable Malignant Biliary Obstruction: A Single-Institution Experience. Duan XH; Wang YL; Han XW; Ren JZ; Li TF; Zhang JH; Zhang K; Chen PF PLoS One; 2015; 10(8):e0134857. PubMed ID: 26244367 [TBL] [Abstract][Full Text] [Related]
30. Effect of endoscopic radiofrequency ablation on the survival of patients with inoperable malignant biliary strictures: A large cohort study. Xia MX; Wang SP; Yuan JG; Gao DJ; Ye X; Wang TT; Wu J; Zhou DX; Hu B J Hepatobiliary Pancreat Sci; 2022 Jun; 29(6):693-702. PubMed ID: 33829657 [TBL] [Abstract][Full Text] [Related]
31. Risk factors for recurrent biliary obstruction following placement of self-expandable metallic stents in patients with malignant perihilar biliary stricture. Miura S; Kanno A; Masamune A; Hamada S; Hongou S; Yoshida N; Nakano E; Takikawa T; Kume K; Kikuta K; Hirota M; Yoshida H; Katayose Y; Unno M; Shimosegawa T Endoscopy; 2016 Jun; 48(6):536-45. PubMed ID: 26987646 [TBL] [Abstract][Full Text] [Related]
32. Percutaneous intraductal radiofrequency ablation for treatment of biliary stent occlusion: A preliminary result. Xia N; Gong J; Lu J; Chen ZJ; Zhang LY; Wang ZM World J Gastroenterol; 2017 Mar; 23(10):1851-1856. PubMed ID: 28348491 [TBL] [Abstract][Full Text] [Related]
33. Percutaneous intraductal radiofrequency ablation for clearance of occluded metal stent in malignant biliary obstruction: feasibility and early results. Pai M; Valek V; Tomas A; Doros A; Quaretti P; Golfieri R; Mosconi C; Habib N Cardiovasc Intervent Radiol; 2014 Feb; 37(1):235-40. PubMed ID: 23842684 [TBL] [Abstract][Full Text] [Related]
34. Combination transarterial chemoembolization and radiofrequency ablation therapy for early hepatocellular carcinoma. Song MJ; Bae SH; Lee JS; Lee SW; Song DS; You CR; Choi JY; Yoon SK Korean J Intern Med; 2016 Mar; 31(2):242-52. PubMed ID: 26874512 [TBL] [Abstract][Full Text] [Related]
35. Outcomes of Salvage Percutaneous Biliary Drainage after Occlusion of Endoscopic Stents. Kessler J; Lee A; Frankel P; Dagis A; Park JJ; Lin J J Vasc Interv Radiol; 2017 Apr; 28(4):594-601. PubMed ID: 28169138 [TBL] [Abstract][Full Text] [Related]
36. Ten-year survival of hepatocellular carcinoma patients undergoing radiofrequency ablation as a first-line treatment. Yang W; Yan K; Goldberg SN; Ahmed M; Lee JC; Wu W; Zhang ZY; Wang S; Chen MH World J Gastroenterol; 2016 Mar; 22(10):2993-3005. PubMed ID: 26973395 [TBL] [Abstract][Full Text] [Related]
37. Unilateral versus bilateral endoscopic metal stenting for malignant hilar biliary obstruction. Naitoh I; Ohara H; Nakazawa T; Ando T; Hayashi K; Okumura F; Okayama Y; Sano H; Kitajima Y; Hirai M; Ban T; Miyabe K; Ueno K; Yamashita H; Joh T J Gastroenterol Hepatol; 2009 Apr; 24(4):552-7. PubMed ID: 19220678 [TBL] [Abstract][Full Text] [Related]
38. Review of endoscopic radiofrequency in biliopancreatic tumours with emphasis on clinical benefits, controversies and safety. Alvarez-Sánchez MV; Napoléon B World J Gastroenterol; 2016 Oct; 22(37):8257-8270. PubMed ID: 27729733 [TBL] [Abstract][Full Text] [Related]
39. [Clinical value of brachytherapy of malignant biliary obstruction after implanting expandable metallic biliary endoprothesis (EMBE)]. Zhang FJ; Wu PH; Gu YK; Zhao M; Fan WJ; Xiao XS Ai Zheng; 2004 Nov; 23(11 Suppl):1567-71. PubMed ID: 15566681 [TBL] [Abstract][Full Text] [Related]
40. ERCP-directed radiofrequency ablation and photodynamic therapy are associated with comparable survival in the treatment of unresectable cholangiocarcinoma. Strand DS; Cosgrove ND; Patrie JT; Cox DG; Bauer TW; Adams RB; Mann JA; Sauer BG; Shami VM; Wang AY Gastrointest Endosc; 2014 Nov; 80(5):794-804. PubMed ID: 24836747 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]